A Review Extended Release Oral Drug Delivery System and Multiparticulate Drug Delivery Systems (MDDS)

Author:

Khambat Swapnil B.1,A. Kale. Shubham1

Affiliation:

1. R. C. Patel Institute of Pharmaceutical Education and Research.Shirpur, Dhule, Maharashtra, India

Abstract

The extended release product will optimize therapeutic effect and safety of a drug at the same time improving the patient convenience and compliance. By incorporating the dose for 24 hrs into one tablet/capsule from which the drug is released slowly. The concept of multiple unit dosage form was initially introduced in the early 1950’s.These forms play a major role in the design of solid dosage form processes because of their unique properties and the flexibility found in their manufacture. These forms can be defined as oral dosage forms consisting of a multiplicity of small discrete units, each exhibiting some desired characteristics. The release of drug from pellets depends on a variety of factors including the carrier used to form pellets and the amount of drug contained in them. Consequently, pellets provide tremendous opportunities for designing new controlled and extended release oral formulations, thus extending the frontier of future pharmaceutical development. The possible mechanism for drug release includes solution/diffusion through the continuous polymer phase or plasticizer channels, diffusion through aqueous pores and osmotically driven release through aqueous pores. To distinguish between these mechanisms, the release rate was studied as a function of coating thickness, plasticizer content and osmotic pressure in the dissolution medium.

Publisher

Technoscience Academy

Subject

General Medicine

Reference21 articles.

1. Pfizer, Detrol® L.A. tolterodine tartrate extended release capsule, http://www.drugbank.ca/system/fda_labels/ DB01036.pdf). Accessed October 2011.

2. Ehab Ahmed MH. Ph.D. Thesis: Application and evaluation of extended release technology to loop diuretics. University of Cincinnati (2002): 78-82.

3. Madhusudhan P and Nazeer S: Extended release formulation. International Journal of Pharmacy and Technology 2010; 2: 625- 684.

4. Hayashi T. Formulation, study and drug release mechanism of a new Theophylline sustained release preparation, Int. J Pharm., 2005; 304: 91-101.

5. Shaji J, Chadawar V and Talwalkar P:Multiparticulate Drug Delivery System. The Indian Pharmacist. 2007;6(60):21-28.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Overview: A Novel Approach on Extended-Release Tablet;Research Journal of Pharmaceutical Dosage Forms and Technology;2024-05-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3